DLH Holdings Corp. provides technology-enabled business process outsourcing, program management solutions, and public health research and analytics services in the United States. It offers digital transformation and cyber security solutions, including artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation to the National Institutes of Health (NIH), Defense Health Agency (DHA), US Army Medical Research and Development Command (MRDC), and US Navy. The company also provides science research and development services and solutions, such as data analytics, testing and evaluation, clinical trials research services, and epidemiology studies to support multiple operating divisions, including NIH and the Center for Disease Control and Prevention, as well as the Military Health System. In addition, it offers systems engineering and integration solutions in the areas of command, control, communications, computers, cyber, intelligence, surveillance, and reconnaissance (C5ISR); modeling, simulation and training, performance-based logistics, and system modernization; and technology-powered health solutions and software engineering on behalf of the US Navy, HHS, VA, and other federal customers. Further, the company holds the trademark, Infinibyte, for cloud-based solution. The company was formerly known as TeamStaff, Inc. and changed its name to DLH Holdings Corp. in June 2012. DLH Holdings Corp. was incorporated in 1969 and is headquartered in Atlanta, Georgia.…
DLH Publishes CEO Letter to Shareholders Highlighting “First 100 Days”
DLH Holdings (NASDAQ: DLHC) is listed on Nasdaq, where its shares trade in USD. It belongs to the Specialty Business Services industry, part of the Industrials sector, and reports about 2,300 employees.
The shares were at 2.730 USD on 20 November 2026, down 53.7% over 52 weeks. Its 52-week range is 2.720 USD to 6.880 USD, and it trades at the bottom of that range.
Its market capitalisation is 39.57M USD.
DLH Holdings reports return on equity of 1.2%, an operating margin of -0.1% and revenue down 46.9% year over year.
Its debt exceeds its cash by 140.91M USD, a debt-to-equity ratio of 1.28. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 7.000 USD is 156.4% above the current price. The next earnings report is expected on 9 December 2026.